Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. (ACOR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ACOR · as of Jun 8, 2026
Key Statistics
Explore Acorda Therapeutics, Inc. Data
acor stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 26.3%
Competitors & Peers
acor competitorsACOR
GRYN
HPCO
LSDI
MNKKQ
NBGVStock Performance
Full HistoryAbout Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing treatments for conditions affecting the nervous system, primarily within the United Stat…
what is acorda therapeutics, inc. · acor stock overview · acorda therapeutics, inc. company profile · who is acorda therapeutics, inc. ceo · acor NASDAQ · acorda therapeutics, inc. headquarters · acorda therapeutics, inc. business segments
About Stock Overview & Key Data
Acorda Therapeutics, Inc. (ACOR) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Feb 10, 2006. As of the latest trading session, ACOR stock price is $0.66, with a market capitalization of $821,028. The stock has returned -96.07% over the past 12 months and -95.58% year-to-date.
According to 19 Wall Street analysts, the consensus rating for Acorda Therapeutics, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2023, Acorda Therapeutics, Inc. reported revenue of $117.6M and net income of -$252.9M. For detailed data — including Acorda Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Acorda Therapeutics, Inc. (ACOR) stock price is $0.66. The stock is traded on NASDAQ under the ticker symbol ACOR. The 52-week range is $0.61 – $24.20.